Short-Term Effect of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection in Perioperative Patients with Type 2 Diabetes Mellitus

Background. Hyperglycemia is common and difficult to control in perioperative patients with type 2 diabetes mellitus (T2DM), which impacts their prognosis after operation. Our study investigated the short-term effect of continuous subcutaneous insulin infusion (CSII) and multiple daily injection (MD...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Song, Jianxuan Wen, Jinming Zhang, Meng Luo, Yue Hu, Yu Zhang, Guanjie Fan, Ling Zhao
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2023/8542262
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547926389293056
author Wei Song
Jianxuan Wen
Jinming Zhang
Meng Luo
Yue Hu
Yu Zhang
Guanjie Fan
Ling Zhao
author_facet Wei Song
Jianxuan Wen
Jinming Zhang
Meng Luo
Yue Hu
Yu Zhang
Guanjie Fan
Ling Zhao
author_sort Wei Song
collection DOAJ
description Background. Hyperglycemia is common and difficult to control in perioperative patients with type 2 diabetes mellitus (T2DM), which impacts their prognosis after operation. Our study investigated the short-term effect of continuous subcutaneous insulin infusion (CSII) and multiple daily injection (MDI) in perioperative T2DM patients using the data envelopment analysis (DEA). Methods. T2DM patients (n=639) who underwent surgeries in Guangdong Provincial Hospital of Traditional Chinese Medicine (2009.01-2017.12) were included. Insulin was provided to each patient during the study and separated into a CSII group (n=369) and an MDI group (n=270). DEA was performed to compare the therapeutic indexes and investigate the short-term effect of the CSII group and MDI group. Results. Scale efficiencies of the CSII group with CCR model and BCC model were better than that of the MDI group. Regarding slack variables, with higher surgical levels, the CSII group was closer to the ideal state than the MDI group, which indicated in improving the average fasting blood glucose (AFBG), antibiotic use days (AUD), preoperative blood glucose control time (PBGCT), first postoperative day fasting blood glucose (FPDFBG), and postoperative hospitalization days (PHD). Conclusion. CSII could effectively control blood glucose levels and shorten perioperative hospitalizing time for T2DM patients, indicating that CSII was beneficial in perioperative period and should be promoted clinically.
format Article
id doaj-art-7a3c3acbf3034ff985307ddb6c4a79c2
institution Kabale University
issn 2314-6753
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-7a3c3acbf3034ff985307ddb6c4a79c22025-02-03T06:42:57ZengWileyJournal of Diabetes Research2314-67532023-01-01202310.1155/2023/8542262Short-Term Effect of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection in Perioperative Patients with Type 2 Diabetes MellitusWei Song0Jianxuan Wen1Jinming Zhang2Meng Luo3Yue Hu4Yu Zhang5Guanjie Fan6Ling Zhao7The Second Affiliated Hospital of GuangzhouThe Second Affiliated Hospital of GuangzhouThe Second Affiliated Hospital of GuangzhouDepartment of EndocrinologySecond Clinical College of GuangzhouSecond Clinical College of GuangzhouThe Second Affiliated Hospital of GuangzhouThe Second Affiliated Hospital of GuangzhouBackground. Hyperglycemia is common and difficult to control in perioperative patients with type 2 diabetes mellitus (T2DM), which impacts their prognosis after operation. Our study investigated the short-term effect of continuous subcutaneous insulin infusion (CSII) and multiple daily injection (MDI) in perioperative T2DM patients using the data envelopment analysis (DEA). Methods. T2DM patients (n=639) who underwent surgeries in Guangdong Provincial Hospital of Traditional Chinese Medicine (2009.01-2017.12) were included. Insulin was provided to each patient during the study and separated into a CSII group (n=369) and an MDI group (n=270). DEA was performed to compare the therapeutic indexes and investigate the short-term effect of the CSII group and MDI group. Results. Scale efficiencies of the CSII group with CCR model and BCC model were better than that of the MDI group. Regarding slack variables, with higher surgical levels, the CSII group was closer to the ideal state than the MDI group, which indicated in improving the average fasting blood glucose (AFBG), antibiotic use days (AUD), preoperative blood glucose control time (PBGCT), first postoperative day fasting blood glucose (FPDFBG), and postoperative hospitalization days (PHD). Conclusion. CSII could effectively control blood glucose levels and shorten perioperative hospitalizing time for T2DM patients, indicating that CSII was beneficial in perioperative period and should be promoted clinically.http://dx.doi.org/10.1155/2023/8542262
spellingShingle Wei Song
Jianxuan Wen
Jinming Zhang
Meng Luo
Yue Hu
Yu Zhang
Guanjie Fan
Ling Zhao
Short-Term Effect of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection in Perioperative Patients with Type 2 Diabetes Mellitus
Journal of Diabetes Research
title Short-Term Effect of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection in Perioperative Patients with Type 2 Diabetes Mellitus
title_full Short-Term Effect of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection in Perioperative Patients with Type 2 Diabetes Mellitus
title_fullStr Short-Term Effect of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection in Perioperative Patients with Type 2 Diabetes Mellitus
title_full_unstemmed Short-Term Effect of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection in Perioperative Patients with Type 2 Diabetes Mellitus
title_short Short-Term Effect of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection in Perioperative Patients with Type 2 Diabetes Mellitus
title_sort short term effect of continuous subcutaneous insulin infusion and multiple daily injection in perioperative patients with type 2 diabetes mellitus
url http://dx.doi.org/10.1155/2023/8542262
work_keys_str_mv AT weisong shorttermeffectofcontinuoussubcutaneousinsulininfusionandmultipledailyinjectioninperioperativepatientswithtype2diabetesmellitus
AT jianxuanwen shorttermeffectofcontinuoussubcutaneousinsulininfusionandmultipledailyinjectioninperioperativepatientswithtype2diabetesmellitus
AT jinmingzhang shorttermeffectofcontinuoussubcutaneousinsulininfusionandmultipledailyinjectioninperioperativepatientswithtype2diabetesmellitus
AT mengluo shorttermeffectofcontinuoussubcutaneousinsulininfusionandmultipledailyinjectioninperioperativepatientswithtype2diabetesmellitus
AT yuehu shorttermeffectofcontinuoussubcutaneousinsulininfusionandmultipledailyinjectioninperioperativepatientswithtype2diabetesmellitus
AT yuzhang shorttermeffectofcontinuoussubcutaneousinsulininfusionandmultipledailyinjectioninperioperativepatientswithtype2diabetesmellitus
AT guanjiefan shorttermeffectofcontinuoussubcutaneousinsulininfusionandmultipledailyinjectioninperioperativepatientswithtype2diabetesmellitus
AT lingzhao shorttermeffectofcontinuoussubcutaneousinsulininfusionandmultipledailyinjectioninperioperativepatientswithtype2diabetesmellitus